CN104762334A - Method for producing peroxyacetic acid by enzyme catalytic reaction - Google Patents
Method for producing peroxyacetic acid by enzyme catalytic reaction Download PDFInfo
- Publication number
- CN104762334A CN104762334A CN201510176728.4A CN201510176728A CN104762334A CN 104762334 A CN104762334 A CN 104762334A CN 201510176728 A CN201510176728 A CN 201510176728A CN 104762334 A CN104762334 A CN 104762334A
- Authority
- CN
- China
- Prior art keywords
- peracetic acid
- reaction
- culture
- enzyme
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01072—Acetylxylan esterase (3.1.1.72)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种酶法生产过氧乙酸的方法,本方法以短链乙酸酯和过氧化氢为底物,由乙酰木聚糖酯酶过水解催化反应生成过氧乙酸。
The invention discloses a method for producing peroxyacetic acid by enzymatic method. The method uses short-chain acetate and hydrogen peroxide as substrates, and acetyl xylan esterase perhydrolysis catalyzes the reaction to generate peracetic acid.
Description
技术领域 technical field
本发明属于基因工程技术领域,具体涉及一种从具有过水解活性的乙酰木聚糖酯酶AXE(Genbank:KC292495)由乙酸酯底物生产过氧乙酸。 The present invention belongs to the technical field of genetic engineering, and specifically relates to the production of peroxyacetic acid from an acetate substrate by acetylxylan esterase AXE (Genbank: KC292495) with perhydrolysis activity.
背景技术 Background technique
过氧乙酸(PAA),别名过醋酸、过氧化乙酸、乙酰过氧化氢,是过氧有机酸中结构简单,合成容易,相对稳定性较好的高活性、强氧化性有机酸。过氧乙酸的氧化能力高于过氧化氢,可作为杀菌消毒剂、氧化剂、环氧化剂,其具有独特的作用,是一种广谱、高效、速效、廉价的灭菌剂,广泛应用于医疗器械消毒、灭菌以及环境、物表、空气等疫原地消毒和预防性消毒。(韩双战,过氧乙酸的合成和应用.河北化工2008(6):41-43.)由于其结构中活性氧的存在,除了用作杀菌消毒剂外,过氧乙酸在造纸纺织、化学合成、环境工程、能源工程、聚合物工业及仿生化学领域都有广泛的应用研究,尤其是作为有机合成中的环氧化剂以及高效杀菌剂,有其突出的优良性能,开发利用前景广阔。(张腾云,等;过氧乙酸的合成及工业应用研究进展.化工进展2007(26):194-197) Peroxyacetic acid (PAA), also known as peracetic acid, peroxyacetic acid, and acetylhydroperoxide, is a highly active and highly oxidizing organic acid with simple structure, easy synthesis, and relatively stable relative stability among peroxyorganic acids. The oxidation ability of peracetic acid is higher than that of hydrogen peroxide, and it can be used as a bactericidal disinfectant, oxidizing agent, and epoxy oxidizing agent. It has unique functions and is a broad-spectrum, efficient, quick-acting, and cheap sterilizing agent. It is widely used in medical devices Disinfection, sterilization, environment, surface, air and other epidemic site disinfection and preventive disinfection. (Han Shuangzhan, Synthesis and application of peracetic acid. Hebei Chemical Industry 2008 (6): 41-43.) Due to the existence of active oxygen in its structure, in addition to being used as a bactericidal disinfectant, peracetic acid is used in papermaking, textiles, chemical synthesis, Environmental engineering, energy engineering, polymer industry and biomimetic chemistry have extensive application research, especially as epoxy oxidants and high-efficiency fungicides in organic synthesis, with outstanding performance and broad prospects for development and utilization. (Zhang Tengyun, et al. Research progress on the synthesis and industrial application of peracetic acid. Chemical Industry Progress 2007(26):194-197)
过氧乙酸的合成方法有很多种, 但目前工业上采用的方法主要是过氧化氢法和乙醛氧化法两种。过氧化氢法是采用醋酸与过氧化氢反应,在强酸的催化作用下,制得过氧乙酸。常使用硫酸作为催化剂,反应过程剧烈,且往往需要高浓度醋酸,得到的过氧乙酸为强酸性。乙醛氧化法是在乙醛氧化生成醋酸的基础上,通过改变乙醛氧化的条件,降低反应温度,获得过氧乙酸。但此反应较复杂,要得到较高的转化率和过氧乙酸得率, 需加入适当的催化剂。且由于过氧乙酸具有强氧化性和腐蚀性,遇明火、高热会引起燃烧爆炸;与还原剂接触、遇金属粉木有燃烧爆炸危险,过氧乙酸的包装和运输及储存都有严格要求。(刘吉起,过氧乙酸的性质、制备和应用.河南预防医学杂志2004(03):171-173) There are many ways to synthesize peracetic acid, but the methods currently used in industry are mainly hydrogen peroxide method and acetaldehyde oxidation method. The hydrogen peroxide method is to use acetic acid and hydrogen peroxide to react, under the catalysis of strong acid, to prepare peracetic acid. Sulfuric acid is often used as a catalyst, the reaction process is violent, and high concentration of acetic acid is often required, and the obtained peracetic acid is strongly acidic. The acetaldehyde oxidation method is based on the oxidation of acetaldehyde to generate acetic acid, by changing the conditions of acetaldehyde oxidation and lowering the reaction temperature to obtain peracetic acid. But this reaction is more complicated, and to obtain higher conversion rate and peracetic acid yield, it is necessary to add an appropriate catalyst. And because peracetic acid has strong oxidizing and corrosive properties, it will cause combustion and explosion when exposed to open flames and high heat; contact with reducing agents, metal powder and wood may cause combustion and explosion hazards, and there are strict requirements for packaging, transportation and storage of peracetic acid. (Liu Jiqi, Properties, Preparation and Application of Peracetic Acid. Henan Journal of Preventive Medicine 2004(03):171-173)
因此,人们开始积极探索生物法生产过氧乙酸。酶法或者微生物法生产过氧乙酸的优点在于反应迅速、温和,不需要高浓度过氧化氢或底物,可以解决运输和储存等问题。酯酶和脂肪酶,其能催化酯水解,据报道常有与非血红素卤代过氧化物重叠的催化活性,能在过氧化氢存在下催化过氧化反应,产生过氧羧酸。反应如下: Therefore, people began to actively explore the biological method to produce peracetic acid. The advantages of enzymatic or microbial production of peracetic acid are rapid and mild reaction, no need for high concentration hydrogen peroxide or substrate, and problems such as transportation and storage can be solved. Esterases and lipases, which catalyze the hydrolysis of esters, are reported to often have overlapping catalytic activity with non-heme haloperoxides, which catalyze peroxidation reactions in the presence of hydrogen peroxide to produce peroxycarboxylic acids. The response is as follows:
例如, O.Kirk等(Biocatalysis,11:65-77(1994)) 研究了水解酶(脂肪酶、酯酶和蛋白酶)催化酰基底物与过氧化氢的过水解以形成过氧羧酸;近期已报道几种蛋白酶和脂肪酶组合原位产生浓度适于用作消毒剂和/或商业漂白剂的过酸(例如过乙酸)(美国专利申请11/413,246和11/588,523)。然而,大多数已知的利用酶生物催化生产的过氧乙酸浓度较低,不具备有效的应用价值。 For example, O. Kirk et al. (Biocatalysis, 11:65-77 (1994)) studied hydrolytic enzymes (lipases, esterases and proteases) catalyzing the perhydrolysis of acyl substrates with hydrogen peroxide to form peroxycarboxylic acids; recently Several protease and lipase combinations have been reported to generate in situ peracids (eg, peracetic acid) at concentrations suitable for use as disinfectants and/or commercial bleaches (US Patent Applications 11/413,246 and 11/588,523). However, most of the known enzyme biocatalyzed production of peracetic acid has a low concentration and does not have effective application value.
实现生物法制备过氧乙酸,最重要的是获得一种易于获取、高活性、高表达的酶,才能达到生产效率高、反应迅速灵敏的要求,进而实现大规模生产。然而,此问题仍然是制约生物法制备过氧乙酸的关键问题。 To realize the biological preparation of peracetic acid, the most important thing is to obtain an enzyme that is easy to obtain, highly active, and highly expressed, so as to meet the requirements of high production efficiency, rapid and sensitive response, and then realize large-scale production. However, this problem is still a key issue restricting the preparation of peracetic acid by biological methods.
发明内容 Contents of the invention
发明人发现,具有自主知识产权(专利申请号CN201210403666.2)的乙酰木聚糖酯酶AXE具有过水解活性,基于此,提出了本发明方案。因此,发明人要求将专利申请CN201210403666.2的内容一并并入本申请,包括申请中乙酰木聚糖酯酶的氨基酸序列SEQ ID NO:2;具有活性的同源三聚体、六聚体蛋白结构;以及基因工程菌大肠杆菌(Escherichia coli)BL21-pET-Cah的构建过程,以及构建获得的菌株。 The inventors found that acetylxylan esterase AXE with independent intellectual property rights (patent application number CN201210403666.2) has perhydrolysis activity, and based on this, proposed the present invention. Therefore, the inventor requests to incorporate the content of the patent application CN201210403666.2 into this application, including the amino acid sequence SEQ ID NO: 2 of the acetylxylan esterase in the application; active homotrimers and hexamers Protein structure; and the construction process of genetically engineered bacteria Escherichia coli ( Escherichia coli ) BL21-pET-Cah, as well as the obtained strains.
本发明所要解决的技术问题在于,获得一种易于获取、高活性、高表达的酶,来进行过氧乙酸的酶法生产。 The technical problem to be solved by the present invention is to obtain an easy-to-obtain, high-activity, high-expression enzyme for the enzymatic production of peracetic acid.
本发明的技术目的在于提供该酯酶在过水解反应中的应用。具体的,可用该酶催化过水解反应,更具体的,在过氧化氢存在情况下,可用该酶催化短链乙酸酯生成过氧乙酸。 The technical purpose of the present invention is to provide the application of the esterase in the perhydrolysis reaction. Specifically, the enzyme can be used to catalyze the perhydrolysis reaction, more specifically, in the presence of hydrogen peroxide, the enzyme can be used to catalyze short-chain acetate to generate peroxyacetic acid.
具体的,本发明的技术方案包括: Specifically, the technical solutions of the present invention include:
具有SEQ ID NO:1 代表的氨基酸序列的乙酰木聚糖酯酶在过水解反应中的应用。 There is the application of the acetylxylan esterase of the amino acid sequence represented by SEQ ID NO:1 in the perhydrolysis reaction.
其中,本申请中SEQ ID NO:1 代表的氨基酸序列与中国专利申请CN201210403666.2中所述SEQ ID NO:2中代表的氨基酸序列一致。首先,发明人发现了该酶具有过水解活性,能够在过氧源存在时催化酰基底物生成过氧酸;其次,对于过水解反应应该理解为,在具有过氧源,如过氧化氢时,酶将酰基底物催化生成过氧酸。 Wherein, the amino acid sequence represented by SEQ ID NO:1 in this application is consistent with the amino acid sequence represented by SEQ ID NO:2 described in Chinese patent application CN201210403666.2. First of all, the inventors have discovered that the enzyme has perhydrolysis activity and can catalyze the generation of peroxyacids from acyl substrates in the presence of a peroxygen source; secondly, the perhydrolysis reaction should be understood as, in the presence of a peroxygen source, such as hydrogen peroxide , the enzyme catalyzes the formation of peroxyacids from acyl substrates.
在优选的反应中,该酶可以在过氧化氢存在条件下催化乙酰基底物生成过氧乙酸。 In a preferred reaction, the enzyme catalyzes the formation of peracetic acid from an acetyl substrate in the presence of hydrogen peroxide.
一种酶催化生产过氧乙酸的方法,以乙酰基底物和过氧化氢为底物,将具有SEQ ID NO:1 代表的氨基酸序列的乙酰木聚糖酯酶与底物接触进行过水解反应生成过氧乙酸。 A method for enzymatically producing peracetic acid, using acetyl substrates and hydrogen peroxide as substrates, contacting acetyl xylan esterase with the amino acid sequence represented by SEQ ID NO: 1 with the substrates to perform a perhydrolysis reaction to generate peracetic acid.
本发明所述的方法,其中,可以以含该酯酶蛋白质的载体为酶催化剂,与底物接触进行过水解反应生成过氧乙酸。 In the method of the present invention, the carrier containing the esterase protein can be used as an enzyme catalyst to contact with the substrate for perhydrolysis reaction to generate peroxyacetic acid.
对于以含该蛋白质的载体为酶催化剂,可以理解为,可以将上述蛋白质在表达体系中表达后纯化、固定化;也可以将上述蛋白质表达后并将表达的菌株破碎,从而获得粗酶液,将粗酶液与底物反应以获取目标产物,或者将粗酶液或者全细胞固定化后将底物与之接触并反应获取目标产物。 For the carrier containing the protein as an enzyme catalyst, it can be understood that the above protein can be purified and immobilized after being expressed in an expression system; the above protein can also be expressed and the expressed strain can be crushed to obtain a crude enzyme solution, React the crude enzyme solution with the substrate to obtain the target product, or immobilize the crude enzyme solution or whole cells, contact the substrate with it and react to obtain the target product.
本发明所述的方法,所述乙酰基底物选自乙酸乙酯、甘油一乙酸酯、甘油二乙酸酯、甘油三乙酸酯中的一种。 In the method of the present invention, the acetyl substrate is selected from one of ethyl acetate, glycerol monoacetate, glycerol diacetate, and glycerol triacetate.
本发明所述的方法,其中,在所述过水解反应体系中,以毫克每毫升计,所述乙酰基底物:过氧化氢:酶的数量比例关系为1:0.5-8.5:0.015-0.075。 The method of the present invention, wherein, in the perhydrolysis reaction system, in milligrams per milliliter, the quantitative ratio of the acetyl substrate: hydrogen peroxide: enzyme is 1:0.5-8.5:0.015-0.075.
对于该比例关系应理解为,有底物种类存在满足的情况下即可实现本发明,而本发明提供的比例为优选的比例。 For this ratio relationship, it should be understood that the present invention can be realized under the condition that the presence of the substrate species is satisfied, and the ratio provided by the present invention is a preferred ratio.
本发明所述的方法,其中,所述过水解反应的反应条件为:pH值6.5-9.5,优选为pH 8.0。 The method of the present invention, wherein the reaction conditions of the perhydrolysis reaction are: pH 6.5-9.5, preferably pH 8.0.
本发明所述的方法,其中,所述过水解反应的反应时间为5分钟到约2小时之内,优选为5分钟之内。 The method of the present invention, wherein, the reaction time of the perhydrolysis reaction is within 5 minutes to about 2 hours, preferably within 5 minutes.
本发明所述的方法,其中,所述过水解反应的温度为20-37℃,优选20℃。 The method of the present invention, wherein the temperature of the perhydrolysis reaction is 20-37°C, preferably 20°C.
对于本发明中过水解的时间、温度、pH值的理解应理解为,有底物种类存在满足的情况下即可实现本发明,而本发明提供的条件为优选条件。 For the understanding of the time, temperature, and pH value of perhydrolysis in the present invention, it should be understood that the present invention can be realized under the condition that there are substrate species, and the conditions provided by the present invention are preferred conditions.
本发明所述的方法,其中,将还包括依据所述蛋白质的编码或氨基酸序列,将蛋白质表达获取粗酶液的过程。 The method of the present invention further includes the process of expressing the protein and obtaining the crude enzyme solution according to the coding or amino acid sequence of the protein.
本发明所述的方法,其中,依次包括如下步骤: The method of the present invention, wherein, comprises the following steps in sequence:
(1)以大肠杆菌(Escherichia coli)BL21/pET-CAH,为出发菌株进行种子培养;其中该大肠杆菌保藏于中国典型培养物保藏中心,保藏编号为:CCTCC NO:M2012408;其中,种子培养培养基为LB培养基;培养条件为:250 mL三角瓶,装液量50 mL,培养温度37℃,摇床转速200 r/min,培养12 h;另外,经破壁获取的粗酶液,还可以通过固定化来进一步进行催化反应。 (1) Escherichia coli ( Escherichia coli ) BL21 / pET-CAH was used as the starting strain for seed culture; the Escherichia coli was preserved in the China Center for Type Culture Collection, and the preservation number was: CCTCC NO: M2012408; among them, the seed culture The base was LB medium; the culture conditions were: 250 mL Erlenmeyer flask, the liquid volume was 50 mL, the culture temperature was 37°C, the shaker speed was 200 r/min, and the culture was 12 h; in addition, the crude enzyme solution obtained by breaking the wall was also The catalytic reaction can be further carried out by immobilization.
本发明的有益效果在于,为生物法催化合成过氧乙酸提供了一种全新的酶制剂。 The invention has the beneficial effects of providing a brand-new enzyme preparation for the catalytic synthesis of peracetic acid by a biological method.
另外,采用本发明的方案可以获取比现有生物法制得的更高的过氧乙酸终浓度。 In addition, the scheme of the present invention can obtain a higher final concentration of peracetic acid than that produced by existing biological methods.
附图说明 Description of drawings
图1为对硝基苯酚(p-NP)浓度-OD405吸光值标准曲线。 Figure 1 is the standard curve of p-nitrophenol (p-NP) concentration-OD405 absorbance value.
图2 为牛血清蛋白(BSA)浓度-OD595吸光值标准曲线。 Figure 2 is the standard curve of bovine serum albumin (BSA) concentration-OD595 absorbance value.
图3 为过氧乙酸(PAA)浓度-OD405吸光值标准曲线。 Figure 3 is the standard curve of peracetic acid (PAA) concentration-OD405 absorbance value.
图4 为最适重组酯酶AXE用量优化实验结果。 Figure 4 shows the experimental results of optimizing the dosage of the most suitable recombinant esterase AX.
图5 为最适甘油三乙酸酯浓度优化实验结果。 Fig. 5 is the optimization experiment result of the optimum triacetin concentration.
图6 为最适过氧化氢浓度优化实验结果。 Figure 6 shows the optimal hydrogen peroxide concentration optimization experiment results.
图7 为最适pH优化实验结果。 Figure 7 is the optimum pH optimization experiment results.
具体实施方式 Detailed ways
下面结合实施例对本发明做进一步说明。所列的实施例仅作阐示之用,并表明本发明的精神和范围并非限于此中的细节及其修改案。 The present invention will be further described below in conjunction with embodiment. The examples listed are for illustrative purposes only, and it is not intended that the spirit and scope of the invention be limited to the details and modifications thereof.
本发明所使用的菌种来源: The strain source used in the present invention:
基因工程菌(Escherichia coli)BL21/pET-CAH为本实验室所有,并保藏于中国典型培养物保藏中心,保藏编号为:CCTCC NO:M2012408。该菌种的具体构建过程,以及酶的鉴定过程参见专利CN 102952787 A。 The genetically engineered bacterium ( Escherichia coli ) BL21/pET-CAH is owned by our laboratory and preserved in the China Center for Type Culture Collection with the preservation number: CCTCC NO: M2012408. For the specific construction process of the strain and the identification process of the enzyme, please refer to the patent CN 102952787 A.
实施例1 本实施例说明酯酶的诱导表达方法。 Example 1 This example illustrates the induced expression method of esterase.
利用基因工程菌诱导表达酯酶的具体方案如下: The specific scheme of utilizing genetically engineered bacteria to induce the expression of esterase is as follows:
(1) 出发菌株:大肠杆菌(Escherichia coli)BL21/pET-CAH; (1) Starting strain: Escherichia coli BL21/pET-CAH;
(2) 种子培养: (2) Seed culture:
培养基:LB培养基:酵母粉 5g/L,蛋白胨10 g/L,氯化钠10 g/L; Medium: LB medium: yeast powder 5g/L, peptone 10 g/L, sodium chloride 10 g/L;
培养条件:250 mL三角瓶,装液量50 mL,培养温度37℃,摇床转速200 r/min,培养12 h; Culture conditions: 250 mL Erlenmeyer flask, liquid volume 50 mL, culture temperature 37°C, shaker speed 200 r/min, culture 12 h;
(3) 发酵培养: (3) Fermentation culture:
培养基组成:LB培养基:酵母粉 5g/L,蛋白胨10 g/L,氯化钠10 g/L; Medium composition: LB medium: yeast powder 5g/L, peptone 10 g/L, sodium chloride 10 g/L;
培养条件:接种量1.5% (v/v),发酵温度37 ℃,当OD达到0.6~0.8时,加异丙基-β-D-硫代吡喃半乳糖苷(IPTG)诱导,IPTG的终浓度1.0 mmol/L,摇床转速180~250 r/min,发酵2-10 h。 Culture conditions: inoculum size 1.5% (v/v), fermentation temperature 37 ℃, when OD reaches 0.6~0.8, add isopropyl-β-D-thiogalactopyranoside (IPTG) to induce, the final IPTG Concentration 1.0 mmol/L, shaker speed 180~250 r/min, fermentation 2-10 h.
(4) 粗酶液的获取: (4) Acquisition of crude enzyme solution:
取出发酵液,8000rpm离心3min,加入1/8 原发酵液体积的Tris-HCl(pH 7.0),浓缩8倍;超声破碎400W、3s 工作时间,7s 间隙时间,超声4min (24次);离心6500 rpm、10 min。上清即为粗酶液。 Take out the fermentation broth, centrifuge at 8000rpm for 3min, add 1/8 volume of the original fermentation broth Tris-HCl (pH 7.0), concentrate 8 times; ultrasonic crushing 400W, 3s working time, 7s gap time, ultrasonic 4min (24 times); centrifuge 6500 rpm, 10 min. The supernatant is the crude enzyme solution.
(5) 酶活力的测定: (5) Determination of enzyme activity:
使用对硝基苯酚乙酸酯为底物,1个酶活单位(U)定义为:在一定反应条件下,每分钟释放1μL p-NP所需的酶量。 Using p-nitrophenol acetate as the substrate, 1 enzyme activity unit (U) was defined as: the amount of enzyme required to release 1 μL p -NP per minute under certain reaction conditions.
标准曲线制作:A溶液的配制:50 mmol/L的磷酸缓冲(pH7.0),其中含有0.6% Triton X-100和0.1%的阿拉伯树胶;B溶液的配制:准确称取0.0139 g pNP标准物质,用A溶液溶解,容量瓶定容至250 mL,配成标准物质浓度为1 μmol/mL的B溶液。采用A溶液对B溶液进行梯度稀释,配成不同浓度的pNP溶液。在酶标板中加入10 μL缓冲液,然后依次加入不同浓度的pNP标准溶液各240 μL,对照中加入A溶液。用酶标仪测定405 nm波长处吸光值。以pNP的浓度作为横坐标,以吸光值作为纵坐标,作标准曲线(图1)。 Preparation of standard curve: preparation of solution A: 50 mmol/L phosphate buffer (pH7.0), which contains 0.6% Triton X-100 and 0.1% gum arabic; preparation of solution B: accurately weigh 0.0139 g p NP standard Substances were dissolved in solution A, and the volumetric flask was adjusted to 250 mL to prepare solution B with a standard substance concentration of 1 μmol/mL. Use solution A to dilute solution B in a gradient manner to prepare p NP solutions with different concentrations. Add 10 μL of buffer solution to the microtiter plate, and then add 240 μL of pNP standard solutions of different concentrations in sequence, and add solution A to the control. The absorbance at a wavelength of 405 nm was measured with a microplate reader. Take the concentration of p NP as the abscissa and the absorbance value as the ordinate to make a standard curve (Figure 1).
测定步骤如下:在反应体系中加入240 μL 底物溶液(A溶液与B溶液按9:1混合),10 μL 适当稀释的酶液,置于水浴锅中,温度为40 ℃,反应时间10 min;使用酶标仪在405 nm处测定吸光值。实验设三个平行,取平均值,并使用10 μL 蒸馏水最为对照组。p-NP标准曲线及方程如图1。 The measurement steps are as follows: add 240 μL of substrate solution (A solution and B solution are mixed at 9:1), 10 μL of appropriately diluted enzyme solution in the reaction system, place in a water bath, the temperature is 40 °C, and the reaction time is 10 min ; Measure the absorbance at 405 nm using a microplate reader. Three parallel experiments were set up, the average value was taken, and 10 μL distilled water was used as the control group. The p -NP standard curve and equation are shown in Figure 1.
测定结果显示:100倍稀释的酶液,A405nm下吸光值分别为:1.449、1.482、1.509,通过标准曲线(图1)计算,对应活性为224.96U/mL。 The measurement results showed that the 100-fold diluted enzyme solution had absorbance values at A405nm of 1.449, 1.482, and 1.509, respectively. Calculated by the standard curve (Figure 1), the corresponding activity was 224.96U/mL.
(6) 蛋白量的测定 (6) Determination of protein amount
使用Brandford法测定蛋白量。 Protein amounts were determined using the Brandford method.
蛋白标曲的制作:配制考马斯亮蓝溶液:100 mg 考马斯亮蓝G-250溶于50 mL 95 % 乙醇中,再加入100 mL 85 %(v/v) H3PO4,最后用蒸馏水稀释至1 l,滤纸过滤后可使用;配制0.1 g/l BSA:称取0.01 g BSA,溶于10 mL 蒸馏水中,使用前用生理盐水配制成0.01、0.02 、0.03、0.04、0.06、0.08 mg/mL;取7个2 mL离心管,编好号(0,1,2,3,4,5,6),在1~6号离心管中分别加入上述稀释后各浓度BSA溶液0.3 mL,最后在每支离心管中加入1.2 mL 考马斯亮蓝溶液。在0号离心管中1.2 mL 考马斯亮蓝溶液和0.3 mL生理盐水。各管混合后后,以0号管为对照测定A595。测得的标准曲线如图2。 Preparation of protein standard song: Prepare Coomassie Brilliant Blue solution: 100 mg Coomassie Brilliant Blue G-250 was dissolved in 50 mL 95 % ethanol, then 100 mL 85 % (v/v) H 3 PO 4 was added, and finally diluted with distilled water to 1 l, can be used after filtering with filter paper; preparation of 0.1 g/l BSA: weigh 0.01 g of BSA, dissolve in 10 mL of distilled water, and prepare 0.01, 0.02, 0.03, 0.04, 0.06, 0.08 mg/mL with normal saline before use ; Take seven 2 mL centrifuge tubes and number them (0, 1, 2, 3, 4, 5, 6), respectively add 0.3 mL of the diluted BSA solution of each concentration above to the centrifuge tubes 1-6, and finally add Add 1.2 mL of Coomassie brilliant blue solution to each centrifuge tube. In a No. 0 centrifuge tube, add 1.2 mL of Coomassie brilliant blue solution and 0.3 mL of normal saline. After mixing the tubes, measure A 595 with tube 0 as a control. The measured standard curve is shown in Figure 2.
蛋白的检测具体步骤如下:首先以牛血清蛋白(BSA)标样的浓度对OD595吸光值作标准曲线方程,如图2。然后去适当稀释的酶液300μL ,加入1.2mL考马斯亮蓝工作液,混匀,室温放置15min,与595nm下测定吸光值。每组做两个平行样,以蒸馏水为空白。 The specific steps of protein detection are as follows: firstly, the standard curve equation is made with the concentration of bovine serum albumin (BSA) standard sample against the OD595 absorbance value, as shown in Figure 2. Then remove 300 μL of appropriately diluted enzyme solution, add 1.2 mL of Coomassie Brilliant Blue working solution, mix well, place at room temperature for 15 min, and measure the absorbance at 595 nm. Two parallel samples were made for each group, and distilled water was used as a blank.
测定结果显示稀释5倍的酶液反应后的OD595吸光值为,0.252、0.277。按照图2的标准曲线计算后,蛋白浓度为:0.16 mg/mL 。因此,工程菌发酵液的乙酰基木聚糖酯酶粗酶液的比酶活力为1406 U/mg。 The measurement results showed that the OD595 absorbance values of the 5-fold diluted enzyme solution after reaction were 0.252 and 0.277. After calculation according to the standard curve in Figure 2, the protein concentration is: 0.16 mg/mL. Therefore, the specific enzyme activity of the acetyl xylan esterase crude enzyme solution of the engineering bacteria fermentation broth was 1406 U/mg.
实施例2 本实施例说明替换基因工程菌表达载体为pET-28a,构建新基因工程菌E. coli BL21pET28a-Cah并对该酯酶进行5L罐规模诱导表达的方法。 Example 2 This example illustrates the method of replacing the expression vector of the genetically engineered bacteria with pET-28a, constructing a new genetically engineered bacteria E. coli BL21pET28a-Cah, and inducing the expression of the esterase in a 5L tank scale.
(1)基因Cah的克隆: (1) Cloning of gene Cah:
根据专利申请号CN201210403666.2中公布的Cah基因(Genbank:KC292495),序列设计合引物: According to the Cah gene (Genbank: KC292495) published in the patent application number CN201210403666.2, the sequence design of the primers:
P1:5’-CATGCCATGGGCATGCAATTATACGACT-3’。 P1: 5'-CATG CCATGG GCATGCAATTATACGACT-3'.
P2:5’-CCCTCGAGGCCTTTCAGATGCGCTT-3’。 P2: 5'-CC CTCGAG GCCTTTCAGATGCGCTT-3'.
引物两端分别引入限制性酶切位点NcoI和XhoI,依照质粒提取试剂盒(OMEGA公司)的说明提取基因工程菌(Escherichia coli)BL21/pET-CAH质粒,以基因工程菌(Escherichia coli)BL21/pET-CAH质粒DNA为模板完成PCR反应; Restriction sites Nco I and Xho I were introduced at both ends of the primers, and the genetically engineered bacteria ( Escherichia coli ) BL21/pET-CAH plasmid was extracted according to the instructions of the plasmid extraction kit (OMEGA company), and the genetically engineered bacteria ( Escherichia coli) ) BL21/pET-CAH plasmid DNA as a template to complete the PCR reaction;
PCR的8管反应体系是:Buffer 22.5μL,ddH2O 141.3μL,MgCl2 13.5μL,dNTP-mix 18μLL,引物P1 4.5μL,引物P2 4.5μL,Taq酶 2.7μL;混合均匀后,分成8管,再向每管加入2μL模板DNA;PCR反应条件:94 ℃预变性 4 min;进行30个循环反应:94 ℃变性45 s,54.1 ℃退火30 s,72 ℃延伸60 s;最后72 ℃保温10 min,反应结束后4 ℃保存;经PCR纯化试剂盒(TaKaRa公司)纯化后,NcoI和XhoI酶切重组回收产物,回收957 bp片段,NcoI和XhoI酶切pET28a载体,回收大片段产物,将双酶切产物在T4DNA连接酶作用下连接获得重组质粒pET28a-Cah。 The 8-tube reaction system for PCR is: Buffer 22.5 μL, ddH2O 141.3 μL, MgCl2 13.5 μL, dNTP-mix 18 μL, primer P1 4.5 μL, primer P2 4.5 μL, Taq enzyme 2.7 μL; Add 2 μL template DNA to each tube; PCR reaction conditions: pre-denaturation at 94 °C for 4 min; perform 30 cycle reactions: denaturation at 94 °C for 45 s, annealing at 54.1 °C for 30 s, extension at 72 °C for 60 s; Store at 4°C after completion; after purification by a PCR purification kit (TaKaRa Company), Nco I and Xho I digested the recombinant recovered product to recover a 957 bp fragment, Nco I and Xho I digested the pET28a vector, recovered a large fragment product, and The double digestion product was ligated under the action of T4 DNA ligase to obtain the recombinant plasmid pET28a-Cah.
(2) 重组基因工程菌的获得: (2) Acquisition of recombinant genetically engineered bacteria:
将重组质粒pET28a-Cah转化E. coli BL21 (DE3),涂布含50 μg/mL的卡那霉素平板,挑取阳性转化子,并进行菌落PCR鉴定,得到重组E.coli,命名为E.coli BL21pET28a-Cah,提取E.coli BL21pET28a-Cah的重组质粒,进行测序验证。 The recombinant plasmid pET28a-Cah was transformed into E. coli BL21 (DE3), spread on a plate containing 50 μg/mL kanamycin, picked positive transformants, and carried out colony PCR identification to obtain recombinant E. coli , named E. .coli BL21pET28a-Cah, the recombinant plasmid of E.coli BL21pET28a-Cah was extracted and verified by sequencing.
(3) 重组基因工程菌E. coli BL21pET28a-Cah 5L罐规模诱导表达的方法 (3) Method for inducing expression of recombinant genetic engineering bacteria E. coli BL21pET28a-Cah 5L tank scale
种子培养: Seed culture:
培养基:LB培养基:酵母粉 5g/L,蛋白胨10 g/L,氯化钠10 g/L; Medium: LB medium: yeast powder 5g/L, peptone 10 g/L, sodium chloride 10 g/L;
培养条件:250 mL三角瓶,装液量50 mL,培养温度37 ℃,摇床转速200 r/min,培养12 h; Culture conditions: 250 mL Erlenmeyer flask, liquid volume 50 mL, culture temperature 37 ℃, shaker speed 200 r/min, culture 12 h;
发酵培养: Fermentation culture:
培养基组成:自诱导培养基:酵母粉 25g/L,胰蛋白胨15 g/L,氯化钠10 g/L,甘油(v/v)0.1%,葡萄糖(w/v)0.2%,乳糖(w/v)0.2%; Medium composition: self-induction medium: yeast powder 25g/L, tryptone 15g/L, sodium chloride 10g/L, glycerol (v/v) 0.1%, glucose (w/v) 0.2%, lactose ( w/v) 0.2%;
培养条件:5L发酵罐,装液量为3L,接种量3.3% (v/v),发酵温度30 ℃,pH7.5,搅拌转速 200 r/min,通气量1.5 vvm发酵16 h。 Culture conditions: 5L fermenter, liquid volume 3L, inoculum size 3.3% (v/v), fermentation temperature 30 ℃, pH 7.5, stirring speed 200 r/min, aeration 1.5 vvm for 16 h.
(4) 粗酶液的获取:参照实例1中粗酶液的获取方法 (4) Acquisition of crude enzyme solution: refer to the acquisition method of crude enzyme solution in Example 1
(5) 酶活力的测定:参照实例1中检测方法进行鉴定。结果表明,经过16小时5L罐自诱导表达,可获得酯酶活力为2.28×104U/ml,通过替换表达载体为pET-28a,并进行5L罐自诱导表达该酯酶(替换昂贵的IPTG诱导剂),说明可以进一步降低生产酯酶培养基成本,从而降低酶法生产过氧乙酸的成本,更有利于实现工业化生产。 (5) Determination of enzyme activity: identify with reference to the detection method in Example 1. The results show that after 16 hours of self-induced expression in a 5L tank, an esterase activity of 2.28×10 4 U/ml can be obtained. By replacing the expression vector with pET-28a, and performing self-induced expression of the esterase in a 5L tank (replacing the expensive IPTG inducer), indicating that the cost of producing esterase medium can be further reduced, thereby reducing the cost of enzymatically producing peracetic acid, which is more conducive to realizing industrial production.
实施例3 本实施例说明以不同短链乙酸酯和过氧化氢为底物,重组酯酶催化生产过氧乙酸及过氧乙酸的检测。 Example 3 This example illustrates the production of peracetic acid and the detection of peracetic acid catalyzed by recombinant esterases using different short-chain acetates and hydrogen peroxide as substrates.
操作步骤: Steps:
(1)按照实施例1中的方法获取酶液; (1) Obtain the enzyme liquid according to the method in Example 1;
(2)利用酯酶催化制备过氧乙酸的反应体系和操作流程:短链乙酸酯底物(乙酸乙酯、甘油一乙酸酯、甘油二乙酸酯、甘油三乙酸酯)0.1g,过氧化氢100 μL(1mol/l),酯酶AXE 30μL (0.3g/ml),0.1mol/l pH7.4磷酸盐缓冲,共1 mL反应体系。其中空白对照中将酶液换成等量缓冲液; (2) Reaction system and operation process for preparing peracetic acid catalyzed by esterase: short-chain acetate substrate (ethyl acetate, glycerol monoacetate, glycerol diacetate, glycerol triacetate) 0.1g , hydrogen peroxide 100 μL (1mol/l), esterase AX 30 μL (0.3g/ml), 0.1mol/l pH7.4 phosphate buffer, a total of 1 mL reaction system. In the blank control, the enzyme solution was replaced with an equal amount of buffer solution;
(3)每个条件下的反应做3个平行,在反应5min、10min、15min时取样; (3) Make 3 parallel reactions under each condition, and take samples at 5 minutes, 10 minutes, and 15 minutes;
(4)产物的处理:反应结束后离心12000rpm,2min后取上层清液,即为反应产物; (4) Product treatment: Centrifuge at 12,000 rpm after the reaction, and take the supernatant after 2 minutes, which is the reaction product;
(5)进行过氧乙酸检测。采用2 ,2-联氮-二(3-乙基-苯并噻唑-6-磺酸)二铵盐(ABTS)的氧化来检测过氧乙酸的浓度。将100μL 经稀释后的反应产物与100μL 0.5g/l ABTS溶液和50μL 1.5mol/l的含有0.03mg/ml 碘化钾的乙酸溶液混合于96孔板中,室温反应10min后,测量其在405nm处吸光度。 (5) Perform peracetic acid detection. The concentration of peracetic acid was detected by oxidation of 2,2-azino-bis(3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt (ABTS). Mix 100 μL of the diluted reaction product with 100 μL of 0.5 g/l ABTS solution and 50 μL of 1.5 mol/l acetic acid solution containing 0.03 mg/ml potassium iodide in a 96-well plate, react at room temperature for 10 minutes, and measure its absorbance at 405 nm .
过氧乙酸标曲的制作:配制0.5g/l ABTS溶液(避光)以及1.5mol/l的含有0.03mg/ml 碘化钾的乙酸溶液:在96孔板编号1~10中依次加入0μL、5μL、10μL、15μL、20μL、25μL、30μL、35μL、40μL、50μL ABTS溶液,100μL、95μL、90μL、85μL、80μL、75μL、70μL 、65μL、60μL、50μL ddH2O,在编号1~10中加入50μL 1.5mol/l的含有0.03mg/ml 碘化钾的乙酸溶液,以及100μL标准过氧乙酸液,混合均匀后室温反应10min,以0号管为对照测定A405。测得的标准曲线如图3。 Preparation of peracetic acid standard song: prepare 0.5g/l ABTS solution (protect from light) and 1.5mol/l acetic acid solution containing 0.03mg/ml potassium iodide: add 0μL, 5μL, 10 μL, 15 μL, 20 μL, 25 μL, 30 μL, 35 μL, 40 μL, 50 μL ABTS solution, 100 μL, 95 μL, 90 μL, 85 μL, 80 μL, 75 μL, 70 μL, 65 μL, 60 μL, 50 μL ddHO, add 50 μL 1.5 to number 1~10 A mol/l acetic acid solution containing 0.03 mg/ml potassium iodide and 100 μL standard peracetic acid solution were mixed evenly and then reacted at room temperature for 10 min. A 405 was measured with No. 0 tube as a control. The measured standard curve is shown in Figure 3.
实验结果如下:25℃下反应5min后所获得的过氧乙酸浓度如表1所示,甘油三乙酸酯作为底物产生的过氧乙酸浓度最高,因此选择甘油三乙酸酯作为底物。 The experimental results are as follows: the concentration of peracetic acid obtained after reacting at 25°C for 5 minutes is shown in Table 1. Triacetin is used as the substrate to produce the highest concentration of peracetic acid, so triacetin is selected as the substrate.
表1. 不同乙酸酯底物生产过氧乙酸浓度Table 1. Concentration of peracetic acid produced by different acetate substrates
实施例4本实施例说明以甘油三乙酸酯和过氧化氢为底物,重组酯酶催化生产过氧乙酸的条件优化 Example 4 This example illustrates the optimization of conditions for the production of peracetic acid catalyzed by recombinant esterase using triacetin and hydrogen peroxide as substrates
1.重组酯酶AXE用量的优化步骤: 1. Optimization steps for the dosage of recombinant esterase AX:
(1) 按照实施例1中的方法获取酶液; (1) Obtain enzyme liquid according to the method in embodiment 1;
(2) 反应体系及条件:对重组酯酶AXE用量进行优化,1ml反应体系中含有250mmol/l甘油三乙酸酯,1mol/l过氧化氢在25℃、pH:7.4条件下反应5min; (2) Reaction system and conditions: optimize the amount of recombinant esterase AXE, 1ml reaction system contains 250mmol/l triacetin, 1mol/l hydrogen peroxide reacts at 25℃, pH:7.4 for 5min;
(3) 按照实施例3中的方法获取过氧乙酸样品并检测。 (3) Obtain and detect peracetic acid samples according to the method in Example 3.
结果表明:如图4所示,随着酯酶的量的增加,催化生产的过氧乙酸的量也在增加,当酯酶增加到0.30mg/ml时,生成的过氧乙酸的量增加缓慢,因此从实际应用与成本考虑,该反应体系中重组酯酶的用量最优为0.30mg/ml,可产生8259ppm过氧乙酸。 The result shows: as shown in Figure 4, along with the increase of the amount of esterase, the amount of the peracetic acid of catalytic production also increases, and when esterase increases to 0.30mg/ml, the amount of the peracetic acid of generation increases slowly , so considering the practical application and cost, the optimum dosage of recombinant esterase in this reaction system is 0.30mg/ml, which can produce 8259ppm peracetic acid.
2.甘油三乙酸酯浓度的优化。 2. Optimization of triacetin concentration.
操作步骤: Steps:
(1) 按照实施例1中的方法获取酶液; (1) Obtain enzyme liquid according to the method in embodiment 1;
(2) 反应体系及条件:对甘油三乙酸酯浓度进行优化,1ml反应体系中含有重组酯酶AXE 0.3mg/ml,1mol/l过氧化氢在25℃、pH:7.4条件下反应5min; (2) Reaction system and conditions: optimize the concentration of triacetin, 1ml reaction system contains recombinant esterase AXE 0.3mg/ml, 1mol/l hydrogen peroxide reacts at 25℃, pH:7.4 for 5min;
(3) 按照实施例3中的方法获取过氧乙酸样品并检测。 (3) Obtain and detect peracetic acid samples according to the method in Example 3.
结果表明:如图5所示,随着甘油三乙酸酯的浓度从100mmol/l增加到300mmol/l,生产的过氧乙酸的量随之增加,但当甘油三乙酸酯浓度高于300mmol/l时,过氧乙酸的量并没有明显增加,因此该反应体系中甘油三乙酸酯的浓度最优为300mmol/l,可产生9613ppm过氧乙酸。 The result shows: as shown in Figure 5, along with the concentration of triacetin increases to 300mmol/l from 100mmol/l, the amount of the peracetic acid of production increases thereupon, but when triacetin concentration is higher than 300mmol When /l, the amount of peracetic acid does not increase significantly, so the concentration of triacetin in this reaction system is optimal 300mmol/l, can produce 9613ppm peracetic acid.
3.过氧化氢浓度的优化 3. Optimization of hydrogen peroxide concentration
操作步骤: Steps:
(1) 按照实施例1中的方法获取酶液; (1) Obtain enzyme liquid according to the method in embodiment 1;
(2) 反应体系及条件:对过氧化氢浓度进行优化,1ml反应体系中含有300mmol/l甘油三乙酸酯,重组酯酶AXE 0.3mg/ml在25℃、pH:7.4条件下反应5min; (2) Reaction system and conditions: optimize the concentration of hydrogen peroxide, 1ml reaction system contains 300mmol/l triacetin, and react 0.3mg/ml recombinant esterase AX at 25℃, pH:7.4 for 5min;
(3) 按照实施例3中的方法获取过氧乙酸样品并检测。 (3) Obtain and detect peracetic acid samples according to the method in Example 3.
结果表明:如图6所示,随着过氧化氢浓度的增加,催化生产的过氧乙酸的量先增加后减少,这可能是由于高浓度的过氧化氢导致酯酶的快速失活引起的。该反应体系中过氧化氢浓度最优为1mol/l,可产生9613ppm过氧乙酸。 The results show that: as shown in Figure 6, with the increase of hydrogen peroxide concentration, the amount of peracetic acid produced by catalysis first increases and then decreases, which may be caused by the rapid inactivation of esterase caused by high concentration of hydrogen peroxide . The optimal concentration of hydrogen peroxide in the reaction system is 1mol/l, which can produce 9613ppm peracetic acid.
4.温度的优化 4. Optimization of temperature
操作步骤: Steps:
(1) 按照实施例1中的方法获取酶液; (1) Obtain enzyme liquid according to the method in embodiment 1;
(2) 反应体系及条件:不同温度下,1ml反应体系中含有300mmol/l甘油三乙酸酯,重组酯酶AXE 0.3mg/m,1mol/l过氧化氢在pH:7.4条件下反应5min; (2) Reaction system and conditions: at different temperatures, 1ml reaction system contains 300mmol/l triacetin, recombinant esterase AX 0.3mg/m, 1mol/l hydrogen peroxide reacts at pH:7.4 for 5min;
(3) 按照实施例3中的方法获取过氧乙酸样品并检测。 (3) Obtain and detect peracetic acid samples according to the method in Example 3.
结果表明,如表2所示,20℃时,生产的过氧乙酸的量达到最高为10481ppm,具有显著的应用价值。 The results show that, as shown in Table 2, at 20°C, the amount of peracetic acid produced reaches a maximum of 10481ppm, which has significant application value.
表2. 反应温度的优化Table 2. Optimization of reaction temperature
5.pH的优化操作步骤: 5. pH optimization operation steps:
(1) 按照实施例1中的方法获取酶液; (1) Obtain enzyme liquid according to the method in embodiment 1;
(2) 反应体系及条件:不同pH条件下,1ml反应体系中含有300mmol/l甘油三乙酸酯,重组酯酶AXE 0.3mg/ml,1mol/l过氧化氢在20℃条件下反应5min; (2) Reaction system and conditions: under different pH conditions, 1ml reaction system contains 300mmol/l triacetin, recombinant esterase AX 0.3mg/ml, 1mol/l hydrogen peroxide at 20°C for 5min;
(3) 按照实施例3中的方法获取过氧乙酸样品并检测。 (3) Obtain and detect peracetic acid samples according to the method in Example 3.
结果表明,如图7所示,pH8.0时,生产的过氧乙酸的量达到最高为11385ppm。 The results showed that, as shown in Figure 7, when the pH was 8.0, the amount of peracetic acid produced reached a maximum of 11385ppm.
实施例5 本实施例说明固定化AXE酯酶生产过氧乙酸的步骤。 Example 5 This example illustrates the steps of producing peracetic acid by immobilizing AX esterase.
(1) 按照实施例1中的方法获取酶液; (1) Obtain enzyme liquid according to the method in embodiment 1;
(2) 重组酯酶AXE的固定化:选择聚丙烯酰胺树脂,利用戊二醛交联法对重组酯酶进行固定化,获得固定化AXE酯酶,对对硝基苯乙酸酯的活力为:17.5U/g (2) Immobilization of recombinant esterase AX: select polyacrylamide resin, use glutaraldehyde cross-linking method to immobilize recombinant esterase, obtain immobilized AX esterase, the activity of p-nitrophenyl acetate is : 17.5U/g
(3) 反应体系及条件:1ml反应体系中含有300mmol/l甘油三乙酸酯,1mol/l过氧化氢,0.5g固定化酶,在pH 8.0、20℃条件下反应5min; (3) Reaction system and conditions: 1ml reaction system contains 300mmol/l triacetin, 1mol/l hydrogen peroxide, 0.5g immobilized enzyme, react at pH 8.0, 20℃ for 5min;
(4) 按照实施例3中的方法获取过氧乙酸样品并检测。 (4) Obtain and detect peracetic acid samples according to the method in Example 3.
结果表明:0.5g固定化后的重组酯酶AXE可产生2678ppm的过氧乙酸。相比于游离酯酶AXE,更便捷可回收使用。重复10次后产生的过氧乙酸为初次反应的72%左右。 The results showed that 0.5g of the immobilized recombinant esterase AXE could produce 2678ppm of peracetic acid. Compared with free esterase AXE, it is more convenient and recyclable. The peracetic acid produced after repeating 10 times was about 72% of the initial reaction.
本发明提供了以下方法,该方法用具有过水解活性的乙酰木聚糖酯酶AXE(游离状态或固定化状态),在过氧化氢(浓度至少200mmol/l)存在下,在酸性至中性反应条件下,从合适的短链乙酸酯(包括甘油酯)原位产生浓过氧乙酸水溶液。 The present invention provides a process using acetylxylan esterase AXE (free or immobilized) having perhydrolytic activity in the presence of hydrogen peroxide (at a concentration of at least 200 mmol/l) at acidic to neutral Concentrated aqueous peracetic acid is generated in situ from suitable short-chain acetates, including glycerides, under reaction conditions.
序列表 sequence listing
<110> 南京工业大学 <110> Nanjing University of Technology
the
<120> 酶催化反应生产过氧乙酸的方法 <120> Method for producing peracetic acid by enzyme-catalyzed reaction
the
<130> xb15041502 <130> xb15041502
the
<160> 2 <160> 2
the
<170> PatentIn version 3.3 <170> PatentIn version 3.3
the
<210> 1 <210> 1
<211> 957 <211> 957
<212> DNA <212> DNA
<213> Bacillus subtilis <213> Bacillus subtilis
the
the
<220> <220>
<221> CDS <221> CDS
<222> (1)..(957) <222> (1)..(957)
the
<400> 1 <400> 1
atg caa tta tac gac ttg ccg ctc gac caa ctg caa acc tat aaa cca 48 atg caa tta tac gac ttg ccg ctc gac caa ctg caa acc tat aaa cca 48
Met Gln Leu Tyr Asp Leu Pro Leu Asp Gln Leu Gln Thr Tyr Lys Pro Met Gln Leu Tyr Asp Leu Pro Leu Asp Gln Leu Gln Thr Tyr Lys Pro
1 5 10 15 1 5 10 15 15
the
aat aaa acc gct cct cat gac ttt tcg gat ttt tgg gca tca tca tta 96 aat aaa acc gct cct cat gac ttt tcg gat ttt tgg gca tca tca tta 96
Asn Lys Thr Ala Pro His Asp Phe Ser Asp Phe Trp Ala Ser Ser Leu Asn Lys Thr Ala Pro His Asp Phe Ser Asp Phe Trp Ala Ser Ser Leu
20 25 30 20 25 30 30
the
cat gag ctt gca aag gaa gag gca aag cct gaa ttg aag gct gaa agc 144 cat gag ctt gca aag gaa gag gca aag cct gaa ttg aag gct gaa agc 144
His Glu Leu Ala Lys Glu Glu Ala Lys Pro Glu Leu Lys Ala Glu Ser His Glu Leu Ala Lys Glu Glu Ala Lys Pro Glu Leu Lys Ala Glu Ser
35 40 45 35 40 45 45
the
tac ccg gct gac ggc gtg aaa gta ttc cgg ctg aca tac cgt agc ttc 192 tac ccg gct gac ggc gtg aaa gta ttc cgg ctg aca tac cgt agc ttc 192
Tyr Pro Ala Asp Gly Val Lys Val Phe Arg Leu Thr Tyr Arg Ser Phe Tyr Pro Ala Asp Gly Val Lys Val Phe Arg Leu Thr Tyr Arg Ser Phe
50 55 60 50 55 60 60
the
ggc aag gcg gaa att gag gga tgg tac gcc gtt ccc gac cgg caa gga 240 ggc aag gcg gaa att gag gga tgg tac gcc gtt ccc gac cgg caa gga 240
Gly Lys Ala Glu Ile Glu Gly Trp Tyr Ala Val Pro Asp Arg Gln Gly Gly Lys Ala Glu Ile Glu Gly Trp Tyr Ala Val Pro Asp Arg Gln Gly
65 70 75 80 65 70 75 80 80
the
ccg cat ccg gcc atc gtg aaa tat cac ggc tat aac gcg agc tat gac 288 ccg cat ccg gcc atc gtg aaa tat cac ggc tat aac gcg agc tat gac 288
Pro His Pro Ala Ile Val Lys Tyr His Gly Tyr Asn Ala Ser Tyr Asp Pro His Pro Ala Ile Val Lys Tyr His Gly Tyr Asn Ala Ser Tyr Asp
85 90 95 85 90 95 95
the
ggg gat ata cat gac atc gta aat tgg gcg ctt cac gga tat gcc gcg 336 ggg gat ata cat gac atc gta aat tgg gcg ctt cac gga tat gcc gcg 336
Gly Asp Ile His Asp Ile Val Asn Trp Ala Leu His Gly Tyr Ala Ala Gly Asp Ile His Asp Ile Val Asn Trp Ala Leu His Gly Tyr Ala Ala
100 105 110 100 105 110
the
ttc ggc atg ctt gtc cgc ggc cag cac agc agc aca gat aca agc gtc 384 ttc ggc atg ctt gtc cgc ggc cag cac agc agc aca gat aca agc gtc 384
Phe Gly Met Leu Val Arg Gly Gln His Ser Ser Thr Asp Thr Ser Val Phe Gly Met Leu Val Arg Gly Gln His Ser Ser Thr Asp Thr Ser Val
115 120 125 115 120 125 125
the
tca ccg cac gga cac gtt ccc ggc tgg atg acg aaa ggg att tta gat 432 tca ccg cac gga cac gtt ccc ggc tgg atg acg aaa ggg att tta gat 432
Ser Pro His Gly His Val Pro Gly Trp Met Thr Lys Gly Ile Leu Asp Ser Pro His Gly His Val Pro Gly Trp Met Thr Lys Gly Ile Leu Asp
130 135 140 130 135 140 140
the
aaa gat aca tat tat tac cgc ggc gtg tac tta gac gcc gtc cgg gct 480 aaa gat aca tat tat tac cgc ggc gtg tac tta gac gcc gtc cgg gct 480
Lys Asp Thr Tyr Tyr Tyr Arg Gly Val Tyr Leu Asp Ala Val Arg Ala Lys Asp Thr Tyr Tyr Tyr Arg Gly Val Tyr Leu Asp Ala Val Arg Ala
145 150 155 160 145 150 155 160
the
ttg gaa gtc atc agc ggc ttt gat gaa gtg gat gaa acg agg atc gcc 528 ttg gaa gtc atc agc ggc ttt gat gaa gtg gat gaa acg agg atc gcc 528
Leu Glu Val Ile Ser Gly Phe Asp Glu Val Asp Glu Thr Arg Ile Ala Leu Glu Val Ile Ser Gly Phe Asp Glu Val Asp Glu Thr Arg Ile Ala
165 170 175 165 170 175
the
gtc atc ggc ggg agc cag gga ggc gga ctt tca atc gct gcg gcg gca 576 gtc atc ggc ggg agc cag gga ggc gga ctt tca atc gct gcg gcg gca 576
Val Ile Gly Gly Ser Gln Gly Gly Gly Leu Ser Ile Ala Ala Ala Ala Val Ile Gly Gly Ser Gln Gly Gly Gly Leu Ser Ile Ala Ala Ala Ala
180 185 190 180 185 190
the
cta tct gat att ccg aga gcg gtt gcg gcc gat tat cct tat tta agc 624 cta tct gat att ccg aga gcg gtt gcg gcc gat tat cct tat tta agc 624
Leu Ser Asp Ile Pro Arg Ala Val Ala Ala Asp Tyr Pro Tyr Leu Ser Leu Ser Asp Ile Pro Arg Ala Val Ala Ala Asp Tyr Pro Tyr Leu Ser
195 200 205 195 200 205 205
the
aat ttt gag cgg gcc att gat gtt gct ctt gat gag ccg tat ctt gag 672 aat ttt gag cgg gcc att gat gtt gct ctt gat gag ccg tat ctt gag 672
Asn Phe Glu Arg Ala Ile Asp Val Ala Leu Asp Glu Pro Tyr Leu Glu Asn Phe Glu Arg Ala Ile Asp Val Ala Leu Asp Glu Pro Tyr Leu Glu
210 215 220 210 215 220 220
the
att aac tcc ttt ttc aga aag aac ggc agc cct gaa acg gag aag acc 720 att aac tcc ttt ttc aga aag aac ggc agc cct gaa acg gag aag acc 720
Ile Asn Ser Phe Phe Arg Lys Asn Gly Ser Pro Glu Thr Glu Lys Thr Ile Asn Ser Phe Phe Arg Lys Asn Gly Ser Pro Glu Thr Glu Lys Thr
225 230 235 240 225 230 235 240
the
gcg atg aat aca ctg gcc tat ttt gat atc atg aat ctg gcg gac cgc 768 gcg atg aat aca ctg gcc tat ttt gat atc atg aat ctg gcg gac cgc 768
Ala Met Asn Thr Leu Ala Tyr Phe Asp Ile Met Asn Leu Ala Asp Arg Ala Met Asn Thr Leu Ala Tyr Phe Asp Ile Met Asn Leu Ala Asp Arg
245 250 255 245 250 255
the
gta aaa gtt ccg gtg ctc atg tcc atc ggg ctg att gac cgc gtg act 816 gta aaa gtt ccg gtg ctc atg tcc atc ggg ctg att gac cgc gtg act 816
Val Lys Val Pro Val Leu Met Ser Ile Gly Leu Ile Asp Arg Val Thr Val Lys Val Pro Val Leu Met Ser Ile Gly Leu Ile Asp Arg Val Thr
260 265 270 260 265 270
the
ccg ccg tcg acg gtg ttt gcc gct tac aat cat ctg gaa acg gaa aaa 864 ccg ccg tcg acg gtg ttt gcc gct tac aat cat ctg gaa acg gaa aaa 864
Pro Pro Ser Thr Val Phe Ala Ala Tyr Asn His Leu Glu Thr Glu Lys Pro Pro Ser Thr Val Phe Ala Ala Tyr Asn His Leu Glu Thr Glu Lys
275 280 285 275 280 285 285
the
caa ttg aag gtt tac cgg tat ttc gga cat gaa tac ata cct tct ttc 912 caa ttg aag gtt tac cgg tat ttc gga cat gaa tac ata cct tct ttc 912
Gln Leu Lys Val Tyr Arg Tyr Phe Gly His Glu Tyr Ile Pro Ser Phe Gln Leu Lys Val Tyr Arg Tyr Phe Gly His Glu Tyr Ile Pro Ser Phe
290 295 300 290 295 300
the
cat acg gaa aag ctg gcc ttt ctg aaa gcg cat ctg aaa ggc tga 957 cat acg gaa aag ctg gcc ttt ctg aaa gcg cat ctg aaa ggc tga 957
His Thr Glu Lys Leu Ala Phe Leu Lys Ala His Leu Lys Gly His Thr Glu Lys Leu Ala Phe Leu Lys Ala His Leu Lys Gly
305 310 315 305 310 315 315
the
the
<210> 2 <210> 2
<211> 318 <211> 318
<212> PRT <212> PRT
<213> Bacillus subtilis <213> Bacillus subtilis
the
<400> 2 <400> 2
the
Met Gln Leu Tyr Asp Leu Pro Leu Asp Gln Leu Gln Thr Tyr Lys Pro Met Gln Leu Tyr Asp Leu Pro Leu Asp Gln Leu Gln Thr Tyr Lys Pro
1 5 10 15 1 5 10 15
the
the
Asn Lys Thr Ala Pro His Asp Phe Ser Asp Phe Trp Ala Ser Ser Leu Asn Lys Thr Ala Pro His Asp Phe Ser Asp Phe Trp Ala Ser Ser Leu
20 25 30 20 25 30
the
the
His Glu Leu Ala Lys Glu Glu Ala Lys Pro Glu Leu Lys Ala Glu Ser His Glu Leu Ala Lys Glu Glu Ala Lys Pro Glu Leu Lys Ala Glu Ser
35 40 45 35 40 45 45
the
the
Tyr Pro Ala Asp Gly Val Lys Val Phe Arg Leu Thr Tyr Arg Ser Phe Tyr Pro Ala Asp Gly Val Lys Val Phe Arg Leu Thr Tyr Arg Ser Phe
50 55 60 50 55 60 60
the
the
Gly Lys Ala Glu Ile Glu Gly Trp Tyr Ala Val Pro Asp Arg Gln Gly Gly Lys Ala Glu Ile Glu Gly Trp Tyr Ala Val Pro Asp Arg Gln Gly
65 70 75 80 65 70 75 80
the
the
Pro His Pro Ala Ile Val Lys Tyr His Gly Tyr Asn Ala Ser Tyr Asp Pro His Pro Ala Ile Val Lys Tyr His Gly Tyr Asn Ala Ser Tyr Asp
85 90 95 85 90 95
the
the
Gly Asp Ile His Asp Ile Val Asn Trp Ala Leu His Gly Tyr Ala Ala Gly Asp Ile His Asp Ile Val Asn Trp Ala Leu His Gly Tyr Ala Ala
100 105 110 100 105 110
the
the
Phe Gly Met Leu Val Arg Gly Gln His Ser Ser Thr Asp Thr Ser Val Phe Gly Met Leu Val Arg Gly Gln His Ser Ser Thr Asp Thr Ser Val
115 120 125 115 120 125
the
the
Ser Pro His Gly His Val Pro Gly Trp Met Thr Lys Gly Ile Leu Asp Ser Pro His Gly His Val Pro Gly Trp Met Thr Lys Gly Ile Leu Asp
130 135 140 130 135 140
the
the
Lys Asp Thr Tyr Tyr Tyr Arg Gly Val Tyr Leu Asp Ala Val Arg Ala Lys Asp Thr Tyr Tyr Tyr Arg Gly Val Tyr Leu Asp Ala Val Arg Ala
145 150 155 160 145 150 155 160
the
the
Leu Glu Val Ile Ser Gly Phe Asp Glu Val Asp Glu Thr Arg Ile Ala Leu Glu Val Ile Ser Gly Phe Asp Glu Val Asp Glu Thr Arg Ile Ala
165 170 175 165 170 175
the
the
Val Ile Gly Gly Ser Gln Gly Gly Gly Leu Ser Ile Ala Ala Ala Ala Val Ile Gly Gly Ser Gln Gly Gly Gly Leu Ser Ile Ala Ala Ala Ala
180 185 190 180 185 190
the
the
Leu Ser Asp Ile Pro Arg Ala Val Ala Ala Asp Tyr Pro Tyr Leu Ser Leu Ser Asp Ile Pro Arg Ala Val Ala Ala Asp Tyr Pro Tyr Leu Ser
195 200 205 195 200 205
the
the
Asn Phe Glu Arg Ala Ile Asp Val Ala Leu Asp Glu Pro Tyr Leu Glu Asn Phe Glu Arg Ala Ile Asp Val Ala Leu Asp Glu Pro Tyr Leu Glu
210 215 220 210 215 220
the
the
Ile Asn Ser Phe Phe Arg Lys Asn Gly Ser Pro Glu Thr Glu Lys Thr Ile Asn Ser Phe Phe Arg Lys Asn Gly Ser Pro Glu Thr Glu Lys Thr
225 230 235 240 225 230 235 240
the
the
Ala Met Asn Thr Leu Ala Tyr Phe Asp Ile Met Asn Leu Ala Asp Arg Ala Met Asn Thr Leu Ala Tyr Phe Asp Ile Met Asn Leu Ala Asp Arg
245 250 255 245 250 255
the
the
Val Lys Val Pro Val Leu Met Ser Ile Gly Leu Ile Asp Arg Val Thr Val Lys Val Pro Val Leu Met Ser Ile Gly Leu Ile Asp Arg Val Thr
260 265 270 260 265 270
the
the
Pro Pro Ser Thr Val Phe Ala Ala Tyr Asn His Leu Glu Thr Glu Lys Pro Pro Ser Thr Val Phe Ala Ala Tyr Asn His Leu Glu Thr Glu Lys
275 280 285 275 280 285
the
the
Gln Leu Lys Val Tyr Arg Tyr Phe Gly His Glu Tyr Ile Pro Ser Phe Gln Leu Lys Val Tyr Arg Tyr Phe Gly His Glu Tyr Ile Pro Ser Phe
290 295 300 290 295 300
the
the
His Thr Glu Lys Leu Ala Phe Leu Lys Ala His Leu Lys Gly His Thr Glu Lys Leu Ala Phe Leu Lys Ala His Leu Lys Gly
305 310 315 305 310 315
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510176728.4A CN104762334A (en) | 2015-04-15 | 2015-04-15 | Method for producing peroxyacetic acid by enzyme catalytic reaction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510176728.4A CN104762334A (en) | 2015-04-15 | 2015-04-15 | Method for producing peroxyacetic acid by enzyme catalytic reaction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104762334A true CN104762334A (en) | 2015-07-08 |
Family
ID=53644425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510176728.4A Pending CN104762334A (en) | 2015-04-15 | 2015-04-15 | Method for producing peroxyacetic acid by enzyme catalytic reaction |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104762334A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101970674A (en) * | 2007-11-21 | 2011-02-09 | 纳幕尔杜邦公司 | Production of peracids using enzymes with perhydrolytic activity |
| CN102782143A (en) * | 2009-10-01 | 2012-11-14 | 纳幕尔杜邦公司 | Perhydrolase for enzymatic peracid production |
| CN102952787A (en) * | 2012-10-22 | 2013-03-06 | 南京工业大学 | Acetyl xylan esterase and application thereof |
| CN103275955A (en) * | 2013-05-26 | 2013-09-04 | 山东隆科特酶制剂有限公司 | Xylosidase Xyl43B with high xylose tolerance, and gene and application thereof |
-
2015
- 2015-04-15 CN CN201510176728.4A patent/CN104762334A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101970674A (en) * | 2007-11-21 | 2011-02-09 | 纳幕尔杜邦公司 | Production of peracids using enzymes with perhydrolytic activity |
| CN102782143A (en) * | 2009-10-01 | 2012-11-14 | 纳幕尔杜邦公司 | Perhydrolase for enzymatic peracid production |
| CN102952787A (en) * | 2012-10-22 | 2013-03-06 | 南京工业大学 | Acetyl xylan esterase and application thereof |
| CN103275955A (en) * | 2013-05-26 | 2013-09-04 | 山东隆科特酶制剂有限公司 | Xylosidase Xyl43B with high xylose tolerance, and gene and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| SEUNG-MOON PARK: "Acetyl xylan esterase of Aspergillus ficcum catalyzed the synthesis of peracetic acid from ethyl acetate and hydrogen peroxide", 《JOURNAL OF BIOSCIENCE AND BIOENGINEERING》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Song et al. | Construction of multiple enzyme metal–organic frameworks biocatalyst via DNA scaffold: A promising strategy for enzyme encapsulation | |
| Sulaiman et al. | Isolation of a novel cutinase homolog with polyethylene terephthalate-degrading activity from leaf-branch compost by using a metagenomic approach | |
| Vaillancourt et al. | The ins and outs of ring-cleaving dioxygenases | |
| Kawata et al. | Enhancement of the organic solvent‐stability of the LST‐03 lipase by directed evolution | |
| CN109943515B (en) | A kind of recombinant bacteria producing carboxylesterase and its application | |
| Azevedo et al. | Thermal and operational stabilities of Hansenula polymorpha alcohol oxidase | |
| Li et al. | Characterization of a uronate dehydrogenase from Thermobispora bispora for production of glucaric acid from hemicellulose substrate | |
| Solyanikova et al. | Benzoate degradation by Rhodococcus opacus 1CP after dormancy: Characterization of dioxygenases involved in the process | |
| CN105543190B (en) | Esterase BSE00077 and coding gene and application thereof | |
| Tao et al. | Efficient production of peracetic acid in aqueous solution with cephalosporin-deacetylating acetyl xylan esterase from Bacillus subtilis | |
| Millar et al. | Esterase EstK from Pseudomonas putida mt‐2: An enantioselective acetylesterase with activity for deacetylation of xylan and poly (vinylacetate) | |
| Ebrahimi et al. | Improvement of thermostability and activity of firefly luciferase through [TMG][Ac] ionic liquid mediator | |
| Balcke et al. | Kinetics of chlorobenzene biodegradation under reduced oxygen levels | |
| CN114182035A (en) | Target nucleic acid instant detection method based on distance signal output | |
| CN104762334A (en) | Method for producing peroxyacetic acid by enzyme catalytic reaction | |
| CN103436506A (en) | Alkaline thermal-stable esterase K91 Est8 and gene thereof | |
| CN102952787B (en) | Acetyl xylan esterase and application thereof | |
| CN104591407B (en) | A kind of method of utilizing restructuring lipoxygenase degradation of triphenylmethane dye | |
| Gonawan et al. | Effect of co‐solvent addition on the reaction kinetics of the lipase‐catalyzed resolution of ibuprofen ester | |
| CN110438176A (en) | With the gene estDR4 of esterase function and its application | |
| Sungkeeree et al. | Efficient removal of toxic phthalate by immobilized serine-type aldehyde-tagged esterase G | |
| CN112143692B (en) | A kind of lovastatin ester hydrolase recombinant strain and construction method and application | |
| CN110066759B (en) | Metal ion and organic solvent resistant carboxylesterase and application thereof | |
| CN108504618A (en) | It is a kind of expression R configuration preferences lipase recombinant bacterium and its application | |
| CN107988307A (en) | The method that enzymatic stereoselectivity splits 2- (4- hydroxy phenyls) propionic acid enantiomer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150708 |